These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17197181)

  • 61. 2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor.
    Pelletier JC; Chengalvala M; Cottom J; Feingold I; Garrick L; Green D; Hauze D; Huselton C; Jetter J; Kao W; Kopf GS; Lundquist JT; Mann C; Mehlmann J; Rogers J; Shanno L; Wrobel J
    Bioorg Med Chem; 2008 Jul; 16(13):6617-40. PubMed ID: 18511284
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors.
    Potashman MH; Bready J; Coxon A; DeMelfi TM; DiPietro L; Doerr N; Elbaum D; Estrada J; Gallant P; Germain J; Gu Y; Harmange JC; Kaufman SA; Kendall R; Kim JL; Kumar GN; Long AM; Neervannan S; Patel VF; Polverino A; Rose P; Plas Sv; Whittington D; Zanon R; Zhao H
    J Med Chem; 2007 Sep; 50(18):4351-73. PubMed ID: 17696416
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Discovery of novel 2-(pyridine-2-yl)-1H-benzimidazole derivatives as potent glucokinase activators.
    Ishikawa M; Nonoshita K; Ogino Y; Nagae Y; Tsukahara D; Hosaka H; Maruki H; Ohyama S; Yoshimoto R; Sasaki K; Nagata Y; Eiki J; Nishimura T
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4450-4. PubMed ID: 19540111
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Benzimidazole-substituted (3-phenoxypropyl)amines as histamine H3 receptor ligands.
    Aslanian R; Zhu X; Vaccaro HA; Shih NY; Piwinski JJ; Williams SM; West RE
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5032-6. PubMed ID: 18752952
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffold.
    Sun C; Robl JA; Wang TC; Huang Y; Kuhns JE; Lupisella JA; Beehler BC; Golla R; Sleph PG; Seethala R; Fura A; Krystek SR; An Y; Malley MF; Sack JS; Salvati ME; Grover GJ; Ostrowski J; Hamann LG
    J Med Chem; 2006 Dec; 49(26):7596-9. PubMed ID: 17181141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sexual dimorphism and androgen regulation of satellite cell population in differentiating rat levator ani muscle.
    Niel L; Willemsen KR; Volante SN; Monks DA
    Dev Neurobiol; 2008 Jan; 68(1):115-22. PubMed ID: 17948238
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS.
    Thevis M; Kohler M; Thomas A; Maurer J; Schlörer N; Kamber M; Schänzer W
    Anal Bioanal Chem; 2008 May; 391(1):251-61. PubMed ID: 18270691
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses: phase 2 dose-response studies.
    Owens W; Gray LE; Zeiger E; Walker M; Yamasaki K; Ashby J; Jacob E
    Environ Health Perspect; 2007 May; 115(5):671-8. PubMed ID: 17520051
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Levonorgestrel antagonism on estrogen-induced pituitary tumors is mediated by progesterone receptors.
    Rey-Roldán EB; Grillo CA; Pietranera L; Libertun C; Nicola AF; Piroli GG
    Horm Metab Res; 2008 Apr; 40(4):245-50. PubMed ID: 18548383
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mass spectrometry of selective androgen receptor modulators.
    Thevis M; Schänzer W
    J Mass Spectrom; 2008 Jul; 43(7):865-76. PubMed ID: 18521833
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
    Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
    Yatkin E; Bernoulli J; Talvitie EM; Santti R
    Int J Androl; 2009 Aug; 32(4):399-410. PubMed ID: 19515173
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.
    Bass R; Perry B; Langenstroer P; Thrasher JB; Dennis KL; Tawfik O; Holzbeierlein J
    J Urol; 2009 Feb; 181(2):615-9; discussion 619-20. PubMed ID: 19091346
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A selective androgen receptor modulator with minimal prostate hypertrophic activity enhances lean body mass in male rats and stimulates sexual behavior in female rats.
    Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Zhang X; Sui Z; Lundeen SG
    Endocrine; 2007 Aug; 32(1):41-51. PubMed ID: 17992601
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.
    Solomon ZJ; Mirabal JR; Mazur DJ; Kohn TP; Lipshultz LI; Pastuszak AW
    Sex Med Rev; 2019 Jan; 7(1):84-94. PubMed ID: 30503797
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A study of the prostate, androgens and sexual activity of male rats.
    Hernandez ME; Soto-Cid A; Aranda-Abreu GE; Díaz R; Rojas F; Garcia LI; Toledo R; Manzo J
    Reprod Biol Endocrinol; 2007 Mar; 5():11. PubMed ID: 17367532
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition of androgen-receptor interaction in mouse prostate gland cytosol by divalent metal ions.
    Donovan MP; Schein LG; Thomas JA
    Mol Pharmacol; 1980 Mar; 17(2):156-62. PubMed ID: 7393202
    [No Abstract]   [Full Text] [Related]  

  • 78. Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitors.
    Ramurthy S; Subramanian S; Aikawa M; Amiri P; Costales A; Dove J; Fong S; Jansen JM; Levine B; Ma S; McBride CM; Michaelian J; Pick T; Poon DJ; Girish S; Shafer CM; Stuart D; Sung L; Renhowe PA
    J Med Chem; 2008 Nov; 51(22):7049-52. PubMed ID: 18942827
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor alpha agonists.
    Yamazaki Y; Abe K; Toma T; Nishikawa M; Ozawa H; Okuda A; Araki T; Oda S; Inoue K; Shibuya K; Staels B; Fruchart JC
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4689-93. PubMed ID: 17553678
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Establishment of a novel immortalized human prostatic epithelial cell line stably expressing androgen receptor and its application for the functional screening of androgen receptor modulators.
    Yu S; Wang MW; Yao X; Chan FL
    Biochem Biophys Res Commun; 2009 May; 382(4):756-61. PubMed ID: 19324023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.